Upgrade to SI Premium - Free Trial

H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy

June 23, 2026 6:07 AM
(Updated - June 23, 2026 6:48 AM EDT)

H.C. Wainwright analyst Matthew Keller initiates coverage on Seres Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage